On the other hand, SMAD4 haploinsufficient KPDC mice (SMAD4(+/−)) lacked RUNX3 expression, had a significantly lower metastatic burden, but showed an increased proliferative activity of the primary tumor compared to KPC tumors. This evidence concerns the gene SMAD4 and neoplasm.